MTVA Stock Analysis: Buy, Sell, or Hold?
MTVA - MetaVia Inc. Common Stock
$1.60
-0.11 (-6.43%)
▼
5d:
-20.4%
30d:
-14.89%
90d:
+8.11%
WAIT
LOW Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When MTVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MTVA is down 20.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MTVA is down 20.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MTVA is currently trading at $1.60, which is considered slightly low relative to its 30-day fair value range of $1.32 to $2.93.
Technical Outlook: Technically, MTVA is showing sideways momentum. The price is currently testing key support at $1.70. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.33 (+1108.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MTVA is showing sideways momentum. The price is currently testing key support at $1.70. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.33 (+1108.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.32 -
$2.93
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 1108.3% below Wall St target ($19.33)
- WARNING: Recommendation downgraded due to -20.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.32 -
$2.93
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$3.80
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.66
Wall Street Target
$19.33
(+1108.3%)
Share & Embed Analysis
Last updated: June 20, 2026 2:55 PM ET
Data refreshes hourly during market hours. Next update: 3:55 PM
Data refreshes hourly during market hours. Next update: 3:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 68 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 65 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 67 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$101 | 62 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
